{"id":"https://openalex.org/W4379512751","doi":"https://doi.org/10.1200/jco.23.00619","title":"Challenging the Value of Minimal Residual Disease in Predicting Outcome of Patients With Chronic Lymphocytic Leukemia","display_name":"Challenging the Value of Minimal Residual Disease in Predicting Outcome of Patients With Chronic Lymphocytic Leukemia","publication_year":2023,"publication_date":"2023-06-06","ids":{"openalex":"https://openalex.org/W4379512751","doi":"https://doi.org/10.1200/jco.23.00619","pmid":"https://pubmed.ncbi.nlm.nih.gov/37279436","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/10351944"},"language":"en","primary_location":{"id":"doi:10.1200/jco.23.00619","doi":"https://doi.org/10.1200/jco.23.00619","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.23.00619","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"},"volume":null,"type":"editorial","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC10351944/pdf/jco-41-3676.pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5036828560","display_name":"Thomas J. Kipps","orcid":"https://orcid.org/0000-0002-0064-4549","observed_orcids":["https://orcid.org/0000-0002-0064-4549"]},"institutions":[{"id":"https://openalex.org/I36258959","display_name":"University of California San Diego","ror":"https://ror.org/0168r3w48","country_code":"US","type":"education","lineage":["https://openalex.org/I36258959"]},{"id":"https://openalex.org/I4390039236","display_name":"Moores Cancer Center","ror":"https://ror.org/01qkmtm61","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2800935791","https://openalex.org/I36258959","https://openalex.org/I4390039236"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Thomas J. Kipps","raw_affiliation_strings":["Department of Medicine, UC San Diego Moores Cancer Center, University of California, San Diego, San Diego, CA"],"raw_orcid":"https://orcid.org/0000-0002-0064-4549","affiliations":[{"raw_affiliation_string":"Department of Medicine, UC San Diego Moores Cancer Center, University of California, San Diego, San Diego, CA","institution_ids":["https://openalex.org/I36258959","https://openalex.org/I4390039236"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5036828560"],"corresponding_institution_ids":["https://openalex.org/I36258959","https://openalex.org/I4390039236"],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":true,"cited_by_count":2,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"41","issue":"21","first_page":"3676","last_page":"3678"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11157","display_name":"Chronic Lymphocytic Leukemia Research","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2716","display_name":"Genetics (clinical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11157","display_name":"Chronic Lymphocytic Leukemia Research","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2716","display_name":"Genetics (clinical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10185","display_name":"Lymphoma Diagnosis and Treatment","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2734","display_name":"Pathology and Forensic Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10950","display_name":"Acute Lymphoblastic Leukemia research","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2739","display_name":"Public Health, Environmental and Occupational Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/chronic-lymphocytic-leukemia","display_name":"chronic lymphocytic leukemia","score":0.9599999785423279},{"id":"https://openalex.org/keywords/measurable-residual-disease","display_name":"minimal residual disease","score":0.9990000128746033},{"id":"https://openalex.org/keywords/progression-free-survival","display_name":"progression-free survival","score":0.9259999990463257},{"id":"https://openalex.org/keywords/surrogate-endpoints","display_name":"surrogate endpoints","score":0.41999998688697815},{"id":"https://openalex.org/keywords/treatment-response-assessment","display_name":"treatment response assessment","score":0.5600000023841858},{"id":"https://openalex.org/keywords/flow-cytometry","display_name":"flow cytometry","score":0.652999997138977},{"id":"https://openalex.org/keywords/clonality","display_name":"clonality","score":0.41600000858306885},{"id":"https://openalex.org/keywords/venetoclax","display_name":"venetoclax","score":0.6809999942779541},{"id":"https://openalex.org/keywords/anti-cd20-monoclonal-antibody","display_name":"anti-CD20 monoclonal antibody","score":0.9179999828338623},{"id":"https://openalex.org/keywords/chemoimmunotherapy","display_name":"chemoimmunotherapy","score":0.9150000214576721},{"id":"https://openalex.org/keywords/fixed-duration-therapy","display_name":"fixed-duration therapy","score":0.6060000061988831},{"id":"https://openalex.org/keywords/remission","display_name":"remission","score":0.4059999883174896},{"id":"https://openalex.org/keywords/prognostic-factors","display_name":"prognostic factors","score":0.5429999828338623}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8862947225570679},{"id":"https://openalex.org/C2777938653","wikidata":"https://www.wikidata.org/wiki/Q1088156","display_name":"Chronic lymphocytic leukemia","level":3,"score":0.8162721395492554},{"id":"https://openalex.org/C2779823535","wikidata":"https://www.wikidata.org/wiki/Q6865356","display_name":"Minimal residual disease","level":3,"score":0.5810258984565735},{"id":"https://openalex.org/C2776291640","wikidata":"https://www.wikidata.org/wiki/Q2912517","display_name":"Value (mathematics)","level":2,"score":0.4680611193180084},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.4550096392631531},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.4383498430252075},{"id":"https://openalex.org/C2778461978","wikidata":"https://www.wikidata.org/wiki/Q29496","display_name":"Leukemia","level":2,"score":0.41609928011894226},{"id":"https://openalex.org/C105795698","wikidata":"https://www.wikidata.org/wiki/Q12483","display_name":"Statistics","level":1,"score":0.13587194681167603},{"id":"https://openalex.org/C33923547","wikidata":"https://www.wikidata.org/wiki/Q395","display_name":"Mathematics","level":0,"score":0.0}],"mesh":[{"descriptor_ui":"D000971","descriptor_name":"Antineoplastic Combined Chemotherapy Protocols","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005434","descriptor_name":"Flow Cytometry","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010361","descriptor_name":"Patients","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015451","descriptor_name":"Leukemia, Lymphocytic, Chronic, B-Cell","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018365","descriptor_name":"Neoplasm, Residual","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":4,"locations":[{"id":"doi:10.1200/jco.23.00619","doi":"https://doi.org/10.1200/jco.23.00619","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.23.00619","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:10351944","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/10351944","pdf_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC10351944/pdf/jco-41-3676.pdf","source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"J Clin Oncol","raw_type":"Text"},{"id":"pmid:37279436","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/37279436","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of clinical oncology : official journal of the American Society of Clinical Oncology","raw_type":"Editorial"},{"id":"pmh:oai:escholarship.org:ark:/13030/qt0xg413n5","doi":null,"is_oa":true,"landing_page_url":"https://escholarship.org/uc/item/0xg413n5","pdf_url":"https://escholarship.org/content/qt0xg413n5/qt0xg413n5.pdf","source":{"id":"https://openalex.org/S4306400115","display_name":"eScholarship (California Digital Library)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I2801248553","host_organization_name":"California Digital Library","host_organization_lineage":["https://openalex.org/I2801248553"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Journal of Clinical Oncology, vol 41, iss 21","raw_type":"article"}],"best_oa_location":{"id":"pmh:oai:pubmedcentral.nih.gov:10351944","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/10351944","pdf_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC10351944/pdf/jco-41-3676.pdf","source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"J Clin Oncol","raw_type":"Text"},"sustainable_development_goals":[{"score":0.9922999739646912,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4379512751.pdf","grobid_xml":"https://content.openalex.org/works/W4379512751.grobid-xml"},"referenced_works_count":11,"referenced_works":["https://openalex.org/W2193060933","https://openalex.org/W2295348655","https://openalex.org/W2513443919","https://openalex.org/W2790385276","https://openalex.org/W2791915815","https://openalex.org/W2902460563","https://openalex.org/W3087507522","https://openalex.org/W4213453359","https://openalex.org/W4214696988","https://openalex.org/W4281254823","https://openalex.org/W4379512915"],"related_works":["https://openalex.org/W2162988002","https://openalex.org/W2221325899","https://openalex.org/W4226457162","https://openalex.org/W2781715502","https://openalex.org/W2584702633","https://openalex.org/W2513443919","https://openalex.org/W2958355556","https://openalex.org/W2081778030","https://openalex.org/W2955478236","https://openalex.org/W2742159800"],"abstract_inverted_index":{"Improvements":[0],"in":[1,215,267,271,362,367,385,427,454,465,491,528,539,548],"treatments":[2],"for":[3,56,76,132,179,196,238,314,335,342,397,415,431,436,451,467,484,523,537,542,567,580,591],"patients":[4,26,83,113,133,550,581],"with":[5,64,135,155,230,259,458,501,553,600],"chronic":[6],"lymphocytic":[7],"leukemia":[8,337,602],"(CLL)":[9],"can":[10,204,257,354,418],"allow":[11],"therapeutic":[12],"eradication":[13],"of":[14,70,146,158,168,233,241,294,381,400,412,424,479,514,519,546,565,588],"any":[15,31,239,272],"detectable":[16,32,122,169],"disease":[17,35,51,159,426,486],"by":[18,99,409,421,597],"even":[19],"the":[20,78,143,156,164,174,242,315,324,336,343,382,410,434,449,455,459,461,477,495,520,578,586,601],"most":[21,175],"sensitive":[22,349],"methods.Intuition":[23],"dictates":[24],"that":[25,68,166,206,261,332,475,504,513,585],"who":[27,48,84,93,114],"do":[28],"not":[29,297,510,574],"have":[30,40,49,85],"minimal":[33],"residual":[34,50,425,485],"(MRD)":[36],"after":[37,52,58,89,124,149,183,441,499],"treatment":[38],"should":[39],"a":[41,96,109,117,180,207,231,299,363,368,398,472,502],"longer":[42,110],"progression-free":[43],"survival":[44],"(PFS)":[45],"than":[46,112,211,265,350,360,512,562],"those":[47,552],"therapy.Clinical":[53],"studies":[54],"evaluating":[55],"MRD":[57,71,87,123,147,170,198,437,453,498,538,547,593],"therapy":[59,150,446,500],"and":[60,137,253,287,296,310,327,353,417],"assessing":[61,77],"its":[62],"relationship":[63],"PFS":[65,111,182],"provided":[66],"evidence":[67],"clearance":[69,167],"may":[72,171,594],"supplant":[73],"other":[74],"metrics":[75],"response":[79,98],"to":[80,152,163,226,289,395,482,535,576],"therapy.For":[81,186],"example,":[82,432],"undetectable":[86],"(uMRD)":[88],"chemoimmunotherapy":[90],"(CIT),":[91],"but":[92,120,281],"achieved":[94,116,558],"only":[95],"partial":[97],"International":[100],"Workshop":[101],"on":[102,192,292],"Chronic":[103],"Lymphocytic":[104],"Leukemia":[105],"criteria,":[106],"1":[107,212,266],"had":[108,115,121,443],"complete":[118],"response,":[119],"therapy.":[125],"2":[126],"Similar":[127],"observations":[128],"subsequently":[129],"were":[130],"made":[131],"treated":[134],"venetoclax":[136],"anti-CD20":[138,444],"monoclonal":[139],"antibodies":[140],"(mAb).3,4":[141],"Moreover,":[142],"relative":[144],"level":[145],"detected":[148],"appeared":[151,555],"correlate":[153],"inversely":[154],"length":[157],"remission.This":[160],"has":[161,190,476],"led":[162],"assumption":[165],"be":[172,419,577,595],"among":[173],"consequential":[176],"surrogate":[177],"markers":[178],"prolonged":[181],"fixed-duration":[184],"(FD)":[185],"this":[187,282,572,589],"reason,":[188],"work":[189],"focused":[191],"defining":[193],"practical":[194],"means":[195],"detecting":[197,452,524],"(Fig":[199],"1).Many":[200],"clinical":[201],"pathology":[202],"laboratories":[203],"certify":[205],"sample":[208,274,369],"contains":[209],"fewer":[210,264,359],"CLL":[213,269,365,387],"cell":[214,244,338],"10,000":[216],"cells":[217,228,270,295,366,413],"(ie,":[218,275,323,370],"<10":[219,276,371],"24":[220],"or":[221,278,373],"MDR4)":[222],"using":[223,559],"flow":[224,308,351,515,560],"cytometry":[225,255,309,352,561],"analyze":[227,483],"stained":[229],"panel":[232],"fluorochrome-conjugated":[234],"antibodies,":[235],"each":[236],"specific":[237],"one":[240,361],"six":[243],"surface":[245],"proteins":[246],"(eg,":[247,402,551],"CD19,":[248],"CD20,":[249],"CD5,":[250],"CD43,":[251],"CD79b,":[252],"CD81).Flow":[254],"actually":[256],"determine":[258,355],"confidence":[260],"there":[262,357],"are":[263,358,393,407],"100,000":[268],"given":[273],"25":[277],"MRD5),":[279],"5":[280],"understandably":[283],"requires":[284],"high-level":[285],"expertise":[286],"attention":[288],"collecting":[290],"data":[291],"millions":[293],"just":[298],"few":[300],"hundred":[301],"thousand.There":[302],"generally":[303,346],"is":[304,333,347,471],"good":[305],"concordance":[306],"between":[307],"molecular":[311,379],"sequencing":[312,340,376],"analysis":[313,341,416,564],"immunoglobulin":[316],"heavy":[317],"(IGH)":[318],"complementarity":[319],"determining":[320],"region":[321],"3":[322],"variable,":[325],"diversity,":[326],"joining":[328],"genes":[329],"[VDJ]":[330],"rearrangement)":[331],"idiosyncratic":[334,568],"population.However,":[339],"VDJ":[344,383,391,469,526,570],"rearrangement":[345,384],"more":[348,556],"whether":[356],"million":[364],"26":[372],"MRD6).However,":[374],"such":[375],"methods":[377],"require":[378],"characterization":[380],"pretreatment":[386],"cells;":[388],"moreover,":[389,541],"some":[390,518,549],"rearrangements":[392,470,527],"difficult":[394],"sequence":[396],"variety":[399],"reasons":[401],"high":[403],"guanine-cytosine":[404],"content).Both":[405],"techniques":[406],"limited":[408],"numbers":[411],"available":[414],"affected":[420],"uneven":[422],"distribution":[423],"sampled":[428],"tissue":[429],"compartments;":[430],"sampling":[433],"blood":[435,456],"within":[438],"3-6":[439],"months":[440],"having":[442],"mAb":[445],"typically":[447],"lowers":[448],"sensitivity":[450,503,587],"compared":[457],"marrow.Assessing":[460],"cell-free":[462],"DNA":[463,529],"(cfDNA)":[464],"plasma":[466],"CLL-associated":[468],"newer":[473],"method":[474],"advantage":[478],"being":[480],"able":[481],"across":[487],"multiple":[488],"compartments":[489],"and,":[490],"theory,":[492],"could":[493],"assess":[494],"total":[496],"body":[497],"appears":[505],"at":[506],"least":[507],"similar,":[508],"if":[509],"greater,":[511],"cytometry.6":[516],"However,":[517],"limitations":[521],"noted":[522],"clonal":[525,569],"extracted":[530],"from":[531],"leukocytes":[532],"also":[533],"apply":[534],"assays":[536],"cfDNA;":[540],"unexplained":[543],"reasons,":[544],"detection":[545],"del(11q))":[554],"readily":[557],"through":[563],"cfDNA":[566],"rearrangements;":[571],"did":[573],"appear":[575],"case":[579],"lacking":[582],"del(11q),":[583],"suggesting":[584],"approach":[590],"monitoring":[592],"influenced":[596],"factors":[598],"associated":[599],"cell's":[603],"cytogenetics.":[604]},"counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2024,"cited_by_count":1}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2023-06-07T00:00:00"}